LeadStory

Bloomberg

Trump admin. weighs crackdown on pharma ads

Bloomberg · 17 days ago
Bloomberg
Bloomberg
17 days ago

The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 billion in annual ad spending.

BreakdownGenerated by LeadStory AI
  • The Trump administration is considering policies to make pharmaceutical advertising to consumers more difficult and costly. 6s
  • Options include requiring more disclosure of side effects in ads and reducing tax deductions for advertising expenses. 14s
  • Health and Human Services Secretary Robert F. Kennedy Jr. argues that direct-to-consumer ads increase unnecessary drug consumption. 43s
  • The United States and New Zealand are the only countries that allow direct pharmaceutical advertising to consumers. 1m 13s
  • Media groups oppose the changes, citing the importance of pharmaceutical ad revenue for funding local news. 1m 19s
PoliticsHealthMedia & Advertising